Strategic Consulting

Building Confidence Through Strategy, Data, and Regulatory Insight

We were particularly impressed with the efficiency and dedication of the MMS team and pleasantly surprised to see deliverables for review ahead of agreed upon deadlines in several instances.
Director, Clinical Data
Midsize Pharma

MMS Strategic Consulting brings together regulatory strategy, statistical consulting, and data expertise to support critical decisions across the drug development lifecycle. These consulting services combine regulatory strategy, statistical consulting and data expertise to help Sponsors make confident, evidence-based decisions that reduce risk and improve outcomes.

MMS strategic consultants collaborate across regulatory, clinical, statistical and biometrics functions to ensure that study designs are scientifically sound, operationally feasible and aligned with the expectations of regulators, investors and internal teams. Every engagement is focused on designing thoughtful trials, creating strong development strategies, and building plans that help move programs forward.

Integrated Support That Aligns Science With Strategy

MMS supports clients through the following:

  • Clinical development and trial design planning
  • End-to-end regulatory strategy and submission preparation
  • Advanced statistical modeling and risk assessment
  • Cross-functional gap analyses and implementation planning
  • Global regulatory pathway evaluation and health authority engagement

View our webinar on innovative trial design and regulatory strategy.

Statistical Consulting That Drives Stronger Trials

MMS statisticians work closely with regulatory experts to ensure that trial designs are ready to answer key questions and stand up to regulatory review. Through platforms like KerusCloud, MMS provides simulation-guided insight to test different trial scenarios, reduce uncertainty and improve planning.

Our depth of support includes:

  • Study design evaluation and protocol development
  • Estimand strategy and endpoint planning
  • Bayesian modeling and complex statistical methods
  • Synthetic control arms and RWD integration
  • Development plan optimization and investor decision support

Learn how data-focused outsourcing strategies are driving better trial outcomes for sponsors.

Regulatory Strategy That Supports Sound Decision-Making

MMS provides regulatory guidance starting with early-stage trials through to global marketing applications. The team applies knowledge of precedent and current standards to help Sponsors shape development plans that are clear and aligned with agency expectations. MMS has supported successful submissions to FDA, EMA, MHRA and other global agencies.

Our depth of support includes:

  • IND, NDA, BLA and MAA strategy and planning
  • Clinical trial application support
  • Health authority meeting preparation and representation
  • Regulatory gap assessments and roadmap creation
  • Strategic content development across modules

Explore insights from our experts on efficiencies for multi-agency submissions.

Continuity From Strategy to Execution

The same MMS statisticians, regulatory leads and writers who support planning stay engaged through execution. This continuity helps avoid disconnects, keeps messaging consistent and strengthens final submissions.

Sponsors choose MMS because they value responsive service, strong scientific support, and a true partnership approach. The MMS team is focused and ready to help you plan and deliver with confidence.

Get to know our values.

Suggested For You

perspectives

July 22nd, 2025

Career Insights: From Military Service to Regulatory Strategy – Ritchie Patton’s Journey at MMS

regulatory intelligence

July 16th, 2025

Navigating the National Priority Review Voucher: Challenges and Solutions 

perspectives

July 15th, 2025

Smart AI, Smarter Oversight: What Sponsors Really Need from Their CRO 

perspectives

July 8th, 2025

Guidance for Working with External Data Vendors – Getting from LPLV to Database Lock Faster

perspectives

July 1st, 2025

Why Real-Time Data Access Matters (and How to Make the Most of It)

webinar

July 31st, 2025

Design, Data, and Decisions in Oncology Trials

perspectives

June 24th, 2025

Why Now Is the Time for Specialized, Data-Focused CRO Partners

news

June 19th, 2025

MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and Dr. Uma Sharma Named CRO Champion 

perspectives

June 17th, 2025

Solving Data Complexity with Real-Time Insights, Predictive AI, and Smarter Decision-Making with Datacise

regulatory intelligence

June 16th, 2025

Key MedDRA Coding Gaps Highlighted at the ISCTM 2025 Scientific Meeting

perspectives

June 10th, 2025

Applying Artificial Intelligence (AI) and Real-World Evidence to Boost Efficiency in Patient Safety Narratives 

perspectives

June 3rd, 2025

Choosing the Right Strategy: Parallel, Sequential, and Staggered Regulatory Submissions